Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep;20(3):423-437.
doi: 10.1007/s42000-021-00275-5. Epub 2021 Feb 19.

Update on vertebral fractures in pituitary diseases: from research to clinical practice

Flaminia Carrone #  1 , Salvatore Ariano #  1 , Sara Piccini  1 , Davide Milani  2 , Marco Mirani  1 , Luca Balzarini  3 , Andrea Gerardo Lania  4   5 , Gherardo Mazziotti  6   7
Affiliations
Review

Update on vertebral fractures in pituitary diseases: from research to clinical practice

Flaminia Carrone et al. Hormones (Athens). 2021 Sep.

Abstract

Derangement of pituitary hormone axes can induce changes in bone remodeling and metabolism with possible alterations in bone microarchitectural structure and increased susceptibility to fractures. Vertebral fractures (VFs), which are a hallmark of skeletal fragility, have been described in a very large number of patients with pituitary diseases. These fractures are clinically relevant, since they predispose to further fractures and may negatively impact on patients' quality of life. However, the management of skeletal fragility and VFs in the specific setting of pituitary diseases is a challenge, since the awareness for this disease is still low, prediction of VFs is uncertain, the diagnosis of VFs cannot be solely based on a clinical approach and also needs a radiological and morphometric approach, the risk of fractures may not be decreased via treatment of pituitary hormone disorders, and the effectiveness of bone-active drugs in this setting is not always evidence-based. This review is an update on skeletal fragility in patients with pituitary diseases, with a focus on clinical and therapeutic aspects concerning the management of VFs.

Keywords: Acromegaly; Cushing’s disease; GH deficiency; Hypogonadism; Osteoporosis; Pituitary diseases; Prolactinoma; Vertebral fractures.

PubMed Disclaimer

References

    1. Mazziotti G, Frara S, Giustina A (2018) Pituitary Diseases and Bone. Endocr Rev 39(4):440–488. https://doi.org/10.1210/er.2018-00005 - DOI - PubMed
    1. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ 3rd (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7(2):221–227. https://doi.org/10.1002/jbmr.5650070214 - DOI - PubMed
    1. Melton LJ 3rd (2003) Adverse outcomes of osteoporotic fractures in the general population. J Bone Miner Res 18(6):1139–1141. https://doi.org/10.1359/jbmr.2003.18.6.1139 - DOI - PubMed
    1. Vasikaran SD, Chubb SA (2016) The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine 52(2):222–225. https://doi.org/10.1007/s12020-016-0900-2 - DOI - PubMed
    1. Schousboe JT, Shepherd JA, Bilezikian JP, Baim S (2013) Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom 16(4):455–466. https://doi.org/10.1016/j.jocd.2013.08.004 - DOI - PubMed

LinkOut - more resources